Be part of the knowledge

Popular

- Ricardo León–Bórquez, MD, MSA
  Peer
- Gustavo Alejandro Lyons
  Peer
0
CME/CE
Optimizando la Evaluación de los Biomarcadores Desde la Biopsia al Testeo en ...
- Mark A. Socinski, MD
  Peer
- Jyoti Patel, MD
  Peer
- Benjamin Levy, MD
  Peer
6
CME/CE
Practical Considerations on the Use of Immune Checkpoint Inhibitors & Chemoth...
- Mitesh J. Borad, MD
  Peer
- Milind Javel, MD
  Peer
8
CME/CE
Rethinking Approaches to Biliary Tract Carcinoma
- Robert Mocharnuk, MD
  Peer
- Joshua Bauml, MD
  Peer
2
CME/CE
Distilling Modern Medical Approaches in Advanced NSCLC: Precision, Performanc...
- Kenneth C. Anderson, MD
  Peer
- Philippe Moreau, MD
  Peer
8
CME/CE
Real-World Treatment Effectiveness Compared with Clinical Trial Efficacy in M...
- Alfredo L. Falcone, MD
  Peer
- Sebastian Stintzing, MD
  Peer
- Tianshu Liu, MD
  Peer
6
CME/CE
Clinical Considerations in Treatment Sequencing for mCRC

Featured

- Scott Kopetz, MD, PhD, FACP
  Peer
- Alberto Sobrero, MD
  Peer
- Rui-Hua Xu, MD
  Peer
19
CME/CE
Improving Clinical Practice in Management of mCRC: A Focus on Tumor Sidedness
- Timothy A. McCarthy, MD
  Peer
14
CME/CE
Precision Oncology: Incorporating Next Generation Sequencing (NGS) in NSCLC
- Edward S. Kim, MD
  Peer
3
Closing the Gaps in NSCLC
The Value of Multidisciplinary Teams in NSCLC Care Plans

Expert Perspectives

- Tanguy Seiwert, MD
  Peer
4
FAQs with Key Opinion Leaders
Current Recommendations: HPV Tumors in Head & Neck Cancers
4
FAQs with Key Opinion Leaders
Recent Breakthroughs in Head and Neck Cancer
3
FAQs with Key Opinion Leaders
Novel Therapies for Head & Neck Cancer
3
Resources
Colorectal Cancer Physician Resources
- Makoto Tahara
  Peer
6
Interviews
Patient Case Study: Role of Cetuximab in treatment of SCC Head and Neck Cance...
10
Interviews
Interview with Makoto Tahara, MD, PhD | Japan
13
Interviews
Interview with Joël Guigay, MD, PhD | France
10
Interviews
Interview with Jan B. Vermorken, MD, PhD | Belgium